Advertisement

Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 600x60px
Document › Details

Teva Pharmaceutical Industries Ltd.. (6/6/17). "Presss Release: Teva to Present at the Jefferies 2017 Global Healthcare Conference". Jerusalem.

Organisations Organisation Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)
  Group Teva (Group)
  Organisation 2 Jefferies Group LLC
  Group Leucadia (Group)
Products Product Jefferies 2017 Global Healthcare Conference New York
  Product 2 pharmaceutical
Index term Index term Teva–Leucadia: investor conference, 201706 supply service Teva presents at Jefferies Healthcare Conference in New York
Persons Person Peterburg, Yitzhak (Teva 201702– Interim CEO)
  Person 2 Hayden, Michael (Teva 201307 President Global RnD + CSO)
     


Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) will host a live audio webcast at the Jefferies 2017 Global Healthcare Conference in New York, NY.


When:
Wednesday, June 7, 2017 at 2:30 PM ET

Who:
Dr. Yitzhak Peterburg, Interim President & CEO,
Dr. Michael Hayden, President of Global R&D & Chief Scientific Officer,
Dipankar Bhattacharjee, President & CEO Global Generic Medicines, Teva Pharmaceutical Industries Ltd.

Where:
http://ir.tevapharm.com

How:
Live over the Internet – log on to the Web at the address above and register for the event (approximately 10 minutes before). An archive of the webcast will be available on Teva’s Website at http://ir.tevapharm.com.


About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is a leading global pharmaceutical company that delivers high-quality, patient-centric healthcare solutions used by approximately 200 million patients in 100 markets every day. Headquartered in Israel, Teva is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,800 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has the world-leading innovative treatment for multiple sclerosis as well as late-stage development programs for other disorders of the central nervous system, including movement disorders, migraine, pain and neurodegenerative conditions, as well as a broad portfolio of respiratory products. Teva is leveraging its generics and specialty capabilities in order to seek new ways of addressing unmet patient needs by combining drug development with devices, services and technologies. Teva's net revenues in 2016 were $21.9 billion. For more information, visit www.tevapharm.com.


Teva Pharmaceutical Industries Ltd.

IR Contacts:
United States
Kevin C. Mannix, 215-591-8912
or
Ran Meir, 215-591-3033
or
Israel
Tomer Amitai, 972 (3) 926-7656

or

PR Contacts:
Israel
Iris Beck Codner, 972 (3) 926-7246
or
United States
Denise Bradley, 215-591-8974

   
Record changed: 2017-07-03

Advertisement

Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 600x60px

More documents for Teva (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BIO Deutschland EBDC 2017 Heidelberg 600x60px




» top

Advertisements

Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Picture [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px Picture BIO Deutschland EBDC 2017 Heidelberg 120x240px Picture EBD Group BioPharm America 2017 BPA Boston MA Startup September 120x80px Picture EBD Group Bio-Europe 2017 BEU Berlin Germany November 120x80px